Phosphorus-32 Therapy

Phosphorus-32 Therapy is a radionuclide-based treatment modality within beta-particle therapy that utilizes the beta-emitting isotope phosphorus-32 to selectively irradiate and ablate malignant or hyperproliferative tissues, distinguished by its specific biochemical uptake in rapidly dividing cells.

115

Publications

3.4K

Citations

369

Authors

94

Institutions

Publications per year

2017–2026

5

Variants

32P Therapy

Authors

369

  1. JH
    John H. Lawrence

    University of California, Berkeley, United States

    7 publications · 201 citations

    7

    h-index

  2. LA
    Lowell A. Erf

    Jefferson Hospital, United States

    5 publications · 121 citations

    5

    h-index

  3. HL
    Hymer L. Friedell

    Case Western Reserve University, United States

    3 publications · 61 citations

    3

    h-index

  4. JM
    Joseph M. Herman

    Johns Hopkins University, United States

    3 publications · 72 citations

    3

    h-index

  5. LF
    Lloyd F. Craver

    Memorial Hospital of South Bend, United States

    3 publications · 53 citations

    3

    h-index

1–5 of 369

Venues

  1. PubMed

    Repository · 12 publications · 329 citations

    11

    h-index

  2. Radiology

    10 publications · 334 citations

    10

    h-index

  3. Cancer

    6 publications · 163 citations

    6

    h-index

  4. Journal of the American Medical Association

    5 publications · 239 citations

    5

    h-index

  5. Archives of Ophthalmology

    4 publications · 70 citations

    4

    h-index

1–5